Evaluation of the Heating Capability and in vitro Hemolysis of Nanosized MgxMn1-xFe2O4 (x = 0.3 and 0.4) Ferrites Prepared by Sol-gel Method
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32804
Evaluation of the Heating Capability and in vitro Hemolysis of Nanosized MgxMn1-xFe2O4 (x = 0.3 and 0.4) Ferrites Prepared by Sol-gel Method

Authors: Laura Elena De León Prado, Dora Alicia Cortés Hernández, Javier Sánchez

Abstract:

Among the different cancer treatments that are currently used, hyperthermia has a promising potential due to the multiple benefits that are obtained by this technique. In general terms, hyperthermia is a method that takes advantage of the sensitivity of cancer cells to heat, in order to damage or destroy them. Within the different ways of supplying heat to cancer cells and achieve their destruction or damage, the use of magnetic nanoparticles has attracted attention due to the capability of these particles to generate heat under the influence of an external magnetic field. In addition, these nanoparticles have a high surface area and sizes similar or even lower than biological entities, which allow their approaching and interaction with a specific region of interest. The most used magnetic nanoparticles for hyperthermia treatment are those based on iron oxides, mainly magnetite and maghemite, due to their biocompatibility, good magnetic properties and chemical stability. However, in order to fulfill more efficiently the requirements that demand the treatment of magnetic hyperthermia, there have been investigations using ferrites that incorporate different metallic ions, such as Mg, Mn, Co, Ca, Ni, Cu, Li, Gd, etc., in their structure. This paper reports the synthesis of nanosized MgxMn1-xFe2O4 (x = 0.3 and 0.4) ferrites by sol-gel method and their evaluation in terms of heating capability and in vitro hemolysis to determine the potential use of these nanoparticles as thermoseeds for the treatment of cancer by magnetic hyperthermia. It was possible to obtain ferrites with nanometric sizes, a single crystalline phase with an inverse spinel structure and a behavior near to that of superparamagnetic materials. Additionally, at concentrations of 10 mg of magnetic material per mL of water, it was possible to reach a temperature of approximately 45°C, which is within the range of temperatures used for the treatment of hyperthermia. The results of the in vitro hemolysis assay showed that, at the concentrations tested, these nanoparticles are non-hemolytic, as their percentage of hemolysis is close to zero. Therefore, these materials can be used as thermoseeds for the treatment of cancer by magnetic hyperthermia.

Keywords: Ferrites, heating capability, hemolysis, nanoparticles, sol-gel.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1131601

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 857

References:


[1] Chicheł, A., Skowronek, J., Kubaszewska, M. & Kanikowski, M. "Hyperthermia – Description of a method and a review of clinical applications." Rep. Pract. Oncol. Radiother. 12, 267–275 (2007).
[2] Bettaieb, A., Wrzal, P. K. & Averill-Bates, D. A., "Cancer Treatment - Conventional and Innovative Approaches" (ed. Rangel, L.) 257–283 (Intech, 2013).
[3] Johannsen, M., Thiesen, B., Wust, P. & Jordan, A. "Magnetic nanoparticle hyperthermia for prostate cancer." Int. J. Hyperthermia 26, 790–795 (2010).
[4] Kumar, C. S. S. R. & Mohammad, F. "Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery." Adv. Drug Deliv. Rev. 63, 789–808 (2011).
[5] Jordan, A., Scholz, R., Wust, P., Fähling, H. & Felix, R. "Magnetic fluid hyperthermia (MFH): Cancer treatment with {AC} magnetic field induced excitation of biocompatible superparamagnetic nanoparticles." J. Magn. Magn. Mater. 201, 413–419 (1999).
[6] Pankhurst, Q. A., Connolly, J., Jones, S. K. & Dobson, J. "Applications of magnetic nanoparticles in biomedicine." J. Phys. Appl. Phys. 36, R167 (2003).
[7] Thiesen, B. & Jordan, A. "Clinical applications of magnetic nanoparticles for hyperthermia." Int. J. Hyperthermia 24, 467–474 (2008).
[8] Shubayev, V. I., II, T. R. P. & Jin, S. "Magnetic nanoparticles for theragnostics." Adv. Drug Deliv. Rev. 61, 467–477 (2009).
[9] Sharifi, I., Shokrollahi, H. & Amiri, S. "Ferrite-based magnetic nanofluids used in hyperthermia applications." J. Magn. Magn. Mater. 324, 903–915 (2012).
[10] Valenzuela, R. "Novel Applications of Ferrites." Phys. Res. Int. 2012, (2012).
[11] Escamilla-Pérez, A. M., Cortés-Hernández, D. A., Almanza-Robles, J. M., Mantovani, D. & Chevallier, P. "Crystal structure of superparamagnetic Mg0.2Ca0.8Fe2O4 nanoparticles synthesized by sol–gel method." J. Magn. Magn. Mater. 374, 474–478 (2015).
[12] Jeun, M., Park, S., Jang, G. H. & Lee, K. H. "Tailoring MgxMn1–xFe2O4 Superparamagnetic Nanoferrites for Magnetic Fluid Hyperthermia Applications." ACS Appl. Mater. Interfaces 6, 16487–16492 (2014).
[13] De-León-Prado, L. E. et al. "Synthesis and characterization of nanosized MgxMn1−xFe2O4 ferrites by both sol-gel and thermal decomposition methods." J. Magn. Magn. Mater. 427, 230–234 (2017).
[14] Iftikhar, A. et al. "Synthesis of super paramagnetic particles of Mn1−xMgxFe2O4 ferrites for hyperthermia applications." J. Alloys Compd. 601, 116–119 (2014).